A team of researchers, using a yeast model of Alzheimer's disease, have identified a drug that could reduce the level of toxic proteins that prevents cellular damage in the brains of AD patients. "We can use this yeast model to find small molecules that will address the underlying cellular pathologies of Alzheimer's, an age-related disease whose burden will become even more significant as our population grows older," says Kent Matlack, a former staff scientist ...
Read More
No comments:
Post a Comment